Vir Biotechnology, Inc.VIRNASDAQ
LOADING
|||
VIR Revenue Growth (YoY Quarterly)•-89.92%
SAPRO
Growth Metrics
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -9.81% | -26.29% | -94.62% | -60.52% | -89.92% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.76% | +1.63% | +1.62% | +1.62% | +1.67% |
| Weighted Average Shares Diluted Growth | +1.76% | +1.63% | +1.62% | +1.62% | +1.67% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -26.73% | -27.11% | -27.10% | -28.57% | -31.96% |
| Book Value per Share Growth | -27.21% | -28.82% | -33.62% | -34.97% | -36.89% |
| Debt Growth | -11.64% | -21.40% | -20.64% | -10.73% | -11.20% |
| R&D Expense Growth | +34.58% | -2.65% | +18.50% | -7.23% | -22.40% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
1 / 4